An observational cohort study comparing effectiveness and safety of thalidomide and lenalidomide in patients with multiple myeloma.

Trial Profile

An observational cohort study comparing effectiveness and safety of thalidomide and lenalidomide in patients with multiple myeloma.

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Nov 2016

At a glance

  • Drugs Lenalidomide (Primary) ; Thalidomide (Primary)
  • Indications Multiple myeloma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 26 Nov 2016 New trial record
    • 17 Nov 2016 Results published in the European Journal of Cancer
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top